Home

Standard BioTools Inc. - Common Stock (LAB)

1.2300
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 24th, 4:08 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Standard BioTools Inc. - Common Stock (LAB)

Agilent Technologies, Inc. A +0.00

Agilent Technologies, Inc. is another significant competitor in the life sciences tools industry, specializing in bioanalytical and measuring technologies. Agilent competes with Standard BioTools by providing a wide array of solutions including mass spectrometry and chromatography, which are essential for analytical chemistry and life science applications. Agilent's established reputation and comprehensive service offerings give it a competitive edge in providing scalable and versatile solutions that cater to a global base of researchers and labs, posing a challenge to Standard BioTools' more focused product range.

Bio-Rad Laboratories, Inc. BIO +0.00

Bio-Rad Laboratories, Inc. operates in the same sphere as Standard BioTools, offering products for life science research and clinical diagnostics. With its extensive range of reagents, instruments, and digital solutions, Bio-Rad competes with Standard BioTools by providing complementary products that cater to various segments in research and diagnostics. Bio-Rad's established market presence and strong customer relationships give it an advantage in areas where standardization and quality assurance are paramount, making it a formidable competitor to Standard BioTools.

Illumina, Inc. ILMN +0.00

Illumina, Inc. is a leading player in the genomic sequencing market, providing advanced tools and technologies that are essential for genomic research. Standard BioTools competes in the life sciences space by offering products that facilitate biomolecular discovery and analysis, but Illumina has a competitive advantage due to its established market dominance in sequencing solutions. As the gold standard for many research applications, Illumina's extensive range of sequencing technologies and strong intellectual property portfolio gives it significant leverage over Standard BioTools, especially in areas related to genomics and proteomics.

Thermo Fisher Scientific Inc. TMO +0.00

Thermo Fisher Scientific Inc. is a major competitor in the life sciences tools and diagnostics market, producing a broad array of products including instruments, reagents, and consumables that serve various segments of biological research and clinical laboratories. While Standard BioTools focuses on specific niche markets within the life sciences, Thermo Fisher has a more extensive product portfolio and global distribution capabilities. This breadth and scale give Thermo Fisher a competitive advantage over Standard BioTools in meeting diverse customer needs, ranging from research to clinical applications.